NEW YORK (AP) — NEW YORK (AP) — Immunic, Inc. (IMUX) on Wednesday reported a loss of $29.6 million in its first quarter.
On a per-share basis, the New York-based company said it had a loss of 30 cents. Losses, adjusted for non-recurring costs, were 25 cents per share.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 27 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IMUX at https://www.zacks.com/ap/IMUX
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
